The management of toxoplasmosis in pregnancy.
D000022:Abortion, Spontaneous / Q000209:etiology; D000032:Abortion, Therapeutic; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D002955:Leucovorin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014122:Toxoplasma / Q000254:growth & development; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control / Q000635:transmission
D013411:Sulfadiazine; D002955:Leucovorin; D011739:Pyrimethamine